Erlotinib 100mg & 150 mg Tablets

Erlotinib 100mg & 150 mg Tablets

  • Medicine name- Erlonat
  • API- Erlotinib
  • Packaging- 30 Tablets
  • Strength- 100mg, 150mg  
  • Manufactured by- Natco Pharma Ltd
Get an Enquiry
Category: Tags: ,

Description

A particular tyrosine kinase inhibitor called Erlotinib tablets is prescribed to treat non-small cell lung cancer (NSCLC) and pancreatic cancer.

It is specifically used to treat non-small lung cancer that has spread metastatically and locally after at least one previous chemotherapy treatment has failed.

It’s also utilized for non-small cell lung cancer that has progressed to other parts of the body and contains either an EGFR exon 21 deletion substitution mutation or an EGFR exon 19 deletion replacement mutation.

Patients may use this drug in conjunction with gemcitabine as a first-line treatment for both locally progressed and metastatic non-small lung cancer.

Dosage and Side Effects

Since Erlotinib (150 mg) is designed to act in a systematic manner by dispersing throughout the body through the bloodstream, it is best administered orally.

It should be taken every day at the same time, with or without food, for optimal benefits. Never attempt to chew on these tablets; instead, split or crush them before swallowing.

The course of treatment should be followed until the condition worsens or a toxic level is reached that is intolerable.

Fatigue, appetite loss, partial hair loss, diarrhea, mouth sores, vomiting, rashes, weight loss, dry skin, eye irritation, weight drop, infection, edema, pyrexia, constipation, bone pain, dyspnea, stomatitis, and myalgia are among the most frequent adverse events.

A few uncommon side effects, including skin toxicity and eye disorders, could also manifest.

Warning and Precautions

  • Before using Erlotinib, it’s important to ensure you don’t have a history of stomach bleeding, eye issues, liver or kidney problems, or lung/breathing troubles.

  • Pregnant women should avoid Erlotinib unless absolutely necessary as it might harm the unborn child. Breastfeeding while taking this medication is not recommended. Ask your doctor for other options.

  • Smoking can reduce the effectiveness of Erlotinib. If you smoke, talk to your doctor. They might adjust the dose cautiously.

  • If you experience sudden breathing problems like shortness of breath, cough, or fever, let your doctor know immediately. If a lung problem is diagnosed, the medicine might need to be stopped, and you’ll get different treatment.

  • Stay hydrated while on this medication. Your doctor may check your kidneys and electrolytes regularly, especially if you’re at risk of dehydration.

  • This medicine may not work the same for everyone with lung cancer, especially if their tumors have certain mutations. It’s also not recommended with certain chemotherapy.

  • Nail and hair problems like brittle or loose nails have been seen in some patients.

  • If you notice any eye issues like redness, tearing, sensitivity to light, blurry vision, pain, or vision changes, contact your doctor right away.

  • There’s a risk of stomach problems with this medication. If you have severe stomach pain, get medical help immediately.

FAQ's

What type of medication is Erlotinib?

Erlotinib belongs to the class of drugs known as receptor tyrosine kinase inhibitors, targeting the epidermal growth factor receptor (EGFR).

When was Erlotinib tablets authorized for medical use?

In the United States, Erlotinib tablets received approval for medical use in 2004.

What are the purposes of Erlotinib?

Erlotinib, an FDA-approved medication, is utilized in treating non-small cell lung cancer (NSCLC) and pancreatic cancer.

Related products